Contract manufacturing organization is a company that serve other companies in the biopharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
This report contains market size and forecasts of Biopharmaceuticals Contract Manufacturing in Global, including the following market information:
Global Biopharmaceuticals Contract Manufacturing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biopharmaceuticals Contract Manufacturing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Biologics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biopharmaceuticals Contract Manufacturing include Boehringer Ingelheim, Lonza Group AG, Inno Biologics Sdn Bhd, Rentschler Biopharma, JRS Pharma, AGC Biologics, ProBioGen, FUJIFILM Diosynth Biotechnologies and Toyobo Co., Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biopharmaceuticals Contract Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biopharmaceuticals Contract Manufacturing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biopharmaceuticals Contract Manufacturing Market Segment Percentages, by Type, 2021 (%)
Biologics
Biosimilars
Global Biopharmaceuticals Contract Manufacturing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biopharmaceuticals Contract Manufacturing Market Segment Percentages, by Application, 2021 (%)
Process Development
Packaging
Others
Global Biopharmaceuticals Contract Manufacturing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biopharmaceuticals Contract Manufacturing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biopharmaceuticals Contract Manufacturing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Biopharmaceuticals Contract Manufacturing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
Lonza Group AG
Inno Biologics Sdn Bhd
Rentschler Biopharma
JRS Pharma
AGC Biologics
ProBioGen
FUJIFILM Diosynth Biotechnologies
Toyobo Co., Ltd.
Samsung Biologics
Thermo Fisher Scientific
Binex Co., Ltd.
WuXi Biologics
AbbVie, Inc.